Table 2.

Agents selected for retesting

Inhibition category	Agents
Antifolates	Pralatrexate
HDAC inhibitor	JNJ-26481585, LBH-589, NVP LAQ824
HSP90 inhibitor	NVP AUY922
Microtubule inhibitor	Cabazitaxel, docetaxel, paclitaxel, vinblastine sulfate, vincristine sulfate
PLK1 inhibitor	BI 2536
Proteasome inhibitor	BORTEZOMIB, carfilzomib
Protein kinases inhibitor	STAUROSPORINE
Pyrimidine analog	Gemcitabine hydrochloride
ROS inducer	ELESCLOMOL
Topoisomerase inhibitor	Mitoxantrone

Agents were selected after stringent statistical analysis from 257 potential candidates. They were listed by their inhibitory mechanisms.